Zhejiang Tailin Bioengineering Co Ltd (300813) — Capital Reinvestment Ratio
Zhejiang Tailin Bioengineering Co Ltd (300813) has a Capital Reinvestment Ratio of 0.67x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥42.25 Million) in capital expenditures (CN¥28.20 Million). See free cash flow generation of Zhejiang Tailin Bioengineering Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Tailin Bioengineering Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Zhejiang Tailin Bioengineering Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang Tailin Bioengineering Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Zhejiang Tailin Bioengineering Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.82x | CN¥57.11 Million | CN¥46.89 Million | ▲ +9.2% |
| 2024 | 0.75x | CN¥24.66 Million | CN¥18.54 Million | ▼ -99.2% |
| 2023 | 91.23x | CN¥1.93 Million | CN¥176.24 Million | ▲ +27880.4% |
| 2022 | 0.33x | CN¥89.39 Million | CN¥29.14 Million | ▼ -54.7% |
| 2021 | 0.72x | CN¥35.96 Million | CN¥25.91 Million | ▲ +983.1% |
| 2020 | 0.07x | CN¥106.28 Million | CN¥7.07 Million | ▼ -91.4% |
| 2019 | 0.77x | CN¥29.04 Million | CN¥22.37 Million | ▼ -32.0% |
| 2018 | 1.13x | CN¥37.33 Million | CN¥42.29 Million | ▼ -1.6% |
| 2017 | 1.15x | CN¥23.04 Million | CN¥26.54 Million | ▲ +155.2% |
| 2016 | 0.45x | CN¥31.56 Million | CN¥14.24 Million | ▲ +398.9% |
| 2015 | 0.09x | CN¥24.54 Million | CN¥2.22 Million | ▲ +48.4% |
| 2014 | 0.06x | CN¥17.51 Million | CN¥1.07 Million | ▼ -69.6% |
| 2013 | 0.20x | CN¥11.51 Million | CN¥2.31 Million | — |